DVA vs UHS
DaVita and Universal Health Services, both Healthcare
DaVita is the larger company at $12B against $11B. On trailing earnings UHS is the cheaper of the two at a P/E of 7.6 against 14.9, a gap that is only a bargain if the two are growing at similar rates. Over the past year DVA returned +38% against -11% for UHS. The RyuScore puts UHS ahead, 79 against 72 out of 100.
| Figure | DVA | UHS |
|---|---|---|
| Last close | $181 | $186 |
| Market cap | $12B | $11B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 14.9 | 7.6 |
| Dividend yield | n/a | 0.4% |
| 1-year return | +38% | -11% |
| 5-year return | +55% | +38% |
| RyuScoresector-relative, 1–10 | 72/100 | 79/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
DaVita
Revenue of $3.6B in Q2 2026, net income $265M. Its largest reported line is U.S.Dialysis With Intersegment, 56% of the disclosed total.
Universal Health Services
Revenue of $4.6B in Q2 2026, net income $358M. Its largest reported line is Managed Care, 31% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.